This resistance of PDAC to ICB has been ascribed to multiple factors, including immune suppressive TME, limited number of CD8+ T cells infiltrating the tumor, or low tumor mutational burden [87], features that have been verified in GEMMs of PDAC [88]. Here, CD8A is linked to neoplasm.